VAZZANO JOSEPH WALTER (Chief Financial Officer) sold 8.7% of their position (49.34K shares) of ABEONA THERAPEUTICS INC. on the open market
Open‑market sale worth $265.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/10/2026ACC: 0001493152-26-028022
Officer· Chief Financial Officer
Since Mar 2022
-49.34K
Net shares
Net seller
$265.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
49.34K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10.27K
Price / share
$5.43
Trade value
$55.77K
% of position
1.8%
6/8/2026
567.77K→557.50K
Common Stock
Direct
Shares
−13.42K
Price / share
$5.30
Trade value
$71.19K
% of position
2.4%
6/9/2026
557.50K→544.08K
Common Stock
Direct
Shares
−25.65K
Price / share
$5.39
Trade value
$138.29K
% of position
4.7%
6/9/2026
544.08K→518.44K
Total
Net shares
−49.34K
Net value
-$265.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2026 | S · Sale | −10.27K | $5.43 | $55.77K | 1.8% | 567.77K | 557.50K |
| Common Stock Direct | 6/9/2026 | S · Sale | −13.42K | $5.30 | $71.19K | 2.4% | 557.50K | 544.08K |
| Common Stock Direct | 6/9/2026 | S · Sale | −25.65K | $5.39 | $138.29K | 4.7% | 544.08K | 518.44K |
| Total | −49.34K | -$265.24K | ||||||
Derivative Transactions0
No derivative transactions reported